Key Laboratory of Gastrointestinal Pharmacology of Chinese Materia Medica of the State Administration of Traditional Chinese Medicine, Department of Pharmacology, School of Pharmacy, Fourth Military Medical University, Xi'an 710032, China.
J Biol Chem. 2013 Jul 5;288(27):20093-9. doi: 10.1074/jbc.M112.426023. Epub 2013 May 7.
PAK1 plays an important role in proliferation and tumorigenesis, at least partially by promoting ERK phosphorylation of C-RAF (Ser-338) or MEK1 (Ser-298). We observed how that overexpression of a kinase-dead mutant form of PAK1 increased phosphorylation of MEK1/2 (Ser-217/Ser-221) and ERK (Thr-202/Tyr-204), although phosphorylation of B-RAF (Ser-445) and C-RAF (Ser-338) remained unchanged. Furthermore, increased activation of the PAK1 activator Rac1 induced the formation of a triple complex of Rac1, PAK1, and MEK1 independent of the kinase activity of PAK1. These data suggest that PAK1 can stimulate MEK activity in a kinase-independent manner, probably by serving as a scaffold to facilitate interaction of C-RAF.
PAK1 在增殖和肿瘤发生中发挥重要作用,至少部分通过促进 ERK 对 C-RAF(Ser-338)或 MEK1(Ser-298)的磷酸化。我们观察到,过表达激酶失活突变形式的 PAK1 增加了 MEK1/2(Ser-217/Ser-221)和 ERK(Thr-202/Tyr-204)的磷酸化,尽管 B-RAF(Ser-445)和 C-RAF(Ser-338)的磷酸化保持不变。此外,PAK1 激活剂 Rac1 的激活增加导致 Rac1、PAK1 和 MEK1 的三聚体复合物的形成,这与 PAK1 的激酶活性无关。这些数据表明 PAK1 可以以激酶非依赖的方式刺激 MEK 活性,可能通过作为支架促进 C-RAF 的相互作用。